Home
About
FAQ
History (1)
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
Moore DC, Elmes JB, Shibu PA, Larck C, Park SI. Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Ann Pharmacother. 2020 Apr; 54(4):371-379.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Drug Eruptions
Humans
Leukemia-Lymphoma, Adult T-Cell
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Middle Aged
Receptors, CCR4
Recurrence
Skin Neoplasms
authors with profiles
Steven Park MD